Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07438444 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

StatusActive, Not Recruiting
PhasePhase 4
Started2026-02-27
View on ClinicalTrials.gov ↗
The main purpose of this study is to measure the safety and efficacy of tirzepatide in adult participants in India who have type 2 diabetes or who have obesity or overweight without type 2 diabetes. Participation in the study will last about 46 weeks.

Amendment history 4 changes detected by DataLookout

2026-08-22
Enrollment closed, study ongoing
2026-08-22
Primary completion moved earlier: 2027-10 → 2027-07
2026-08-22
Completion moved earlier: 2027-10 → 2027-07
2026-04-22
Recruitment opened
Trial Details
NCT Number NCT07438444
Lead Sponsor Eli Lilly and Company
Conditions Diabetes Mellitus, Type 2, Obesity, Overweight
Enrollment 344 participants
Start Date 2026-02-27
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-21